| 1 |
Follow-up study of thymomas with special reference to their clinical stages
Akira Masaoka, Yasumasa Monden, Kazuya Nakahara et al. · Cancer
|
Dec 1981 |
1,725 |
| 2 |
Myasthenia gravis
Alfred Jaretzki, Richard J. Barohn, Raina M. Ernstoff et al. · Neurology
|
12 Jul 2000 |
1,657 |
| 3 |
Localized mediastinal lymph-node hyperplasia resembling thymoma
Benjamin Castleman, Lalla Iverson, V. Pardo Menendez · Cancer
Open access |
Jul 1956 |
1,635 |
| 4 |
Paresis Acquired in the Intensive Care Unit A Prospective Multicenter Study
Bernard De Jonghe · JAMA
|
11 Dec 2002 |
1,533 |
| 5 |
Myasthenia gravis: subgroup classification and therapeutic strategies
Nils Erik Gilhus, Jan J.G.M. Verschuuren · The Lancet Neurology
|
13 Sep 2015 |
1,262 |
| 6 |
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
Werner Hoch, John McConville, Sigrun Helms et al. · Nature Medicine
|
Mar 2001 |
1,195 |
| 7 |
International consensus guidance for management of myasthenia gravis
Donald B. Sanders, Gil I. Wolfe, Michael G Benatar et al. · Neurology
Open access |
29 Jun 2016 |
1,190 |
| 8 |
Antibody to acetylcholine receptor in myasthenia gravis
Jon Martin Lindstrom, Marjorie E. Seybold, Vanda A. Lennon et al. · Neurology
Open access |
Nov 1976 |
1,189 |
| 9 |
Myasthenia Gravis
Daniel B. Drachman · New England Journal of Medicine
|
23 Jun 1994 |
1,159 |
| 10 |
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
Sakir Humayun Gultekin · Brain
|
Jul 2000 |
1,128 |
| 11 |
Clinical Variation of Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy (APECED) in a Series of 68 Patients
Pekka Ahonen, Sinikka Myllärniemi, Ilkka Sipilä et al. · New England Journal of Medicine
Open access |
28 Jun 1990 |
1,088 |
| 12 |
Myasthenia Gravis
Nils Erik Gilhus · New England Journal of Medicine
|
28 Dec 2016 |
1,063 |
| 13 |
Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: International standards guideline statement
Gregory W. Randolph et al. · The Laryngoscope
Open access |
3 Aug 2010 |
1,047 |
| 14 |
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
David J. Sugarbaker, Raja Michael Flores, Michael T. Jaklitsch et al. · Journal of Thoracic and Cardiovascular Surgery
Open access |
1999 |
990 |
| 15 |
Randomized Trial of Thymectomy in Myasthenia Gravis
Gil I. Wolfe et al. · New England Journal of Medicine
Open access |
10 Aug 2016 |
933 |
| 16 |
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Matthew N. Meriggioli, Donald B. Sanders · The Lancet Neurology
Open access |
17 Apr 2009 |
894 |
| 17 |
Estimation of Somatomedin-C Levels in Normals and Patients with Pituitary Disease by Radioimmunoassay
Richard W. Furlanetto, Louis E. Underwood, Judson J. Van Wyk et al. · Journal of Clinical Investigation
Open access |
Sep 1977 |
854 |
| 18 |
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard et al. · The Lancet Neurology
624 authors |
23 Oct 2017 |
844 |
| 19 |
Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan
Kazuya Kondo, Yasumasa Monden · The Annals of Thoracic Surgery
Open access |
Sep 2003 |
811 |
| 20 |
A systematic review of population based epidemiological studies in Myasthenia Gravis
Aisling S. Carr, Chris R. Cardwell, Peter O McCarron et al. · BMC Neurology
ReviewOpen access |
18 Jun 2010 |
768 |
| 21 |
Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositis
Shinji Sato, Michito Hirakata, Masataka Kuwana et al. · Arthritis & Rheumatism
|
May 2005 |
755 |
| 22 |
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Francesc Graus, Alberto Vogrig, Sergio Muñiz‐Castrillo et al. · Neurology Neuroimmunology & Neuroinflammation
Open access |
18 May 2021 |
750 |
| 23 |
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M. Gross et al. · New England Journal of Medicine
Open access |
18 Mar 2020 |
739 |
| 24 |
Lifetime course of myasthenia gravis
David Tim Grob, Norman G. Brunner, Tatsuji Namba et al. · Muscle & Nerve
|
4 Dec 2007 |
739 |
| 25 |
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
Anne Puel et al. · The Journal of Experimental Medicine
Open access |
Feb 2010 |
735 |
| 26 |
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
Eric Lancaster, Maartje G. M. Huijbers, Vered Bar et al. · Annals of Neurology
Open access |
29 Oct 2010 |
734 |
| 27 |
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
James F. Howard et al. · The Lancet Neurology
Open access218 authors |
16 Jun 2021 |
725 |
| 28 |
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
Ioannis Ilias, David James Torpy, Karel Pacák et al. · The Journal of Clinical Endocrinology & Metabolism
|
Aug 2005 |
716 |
| 29 |
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
Tom Treasure, Loı̈c Lang-Lazdunski, David A. Waller et al. · The Lancet Oncology
Open access |
5 Jul 2011 |
716 |
| 30 |
Towards global optimization 2
H.-J. Zimmermann · European Journal of Operational Research
|
Jul 1979 |
701 |
| 31 |
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Daniel E. Fürst, Edward Clark Keystone, Jürgen Braun et al. · Annals of the Rheumatic Diseases
|
21 Feb 2011 |
691 |
| 32 |
Myasthenia gravis: past, present, and future
Bianca M. Conti‐Fine, Monica Milani, Henry J. Kaminski · Journal of Clinical Investigation
Open access |
Nov 2006 |
691 |
| 33 |
Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK
Natalie Kim, Amy L. Stiegler, Thomas O. Cameron et al. · Cell
Open access |
Oct 2008 |
690 |
| 34 |
THE LAMBERT-EATON MYASTHENIC SYNDROME
Jane O’Neill, Nicholas M.F. Murray, John Newsom–Davis · Brain
|
1988 |
686 |
| 35 |
Glucocorticoids and invasive fungal infections
Michail S. Lionakis, Dimitrios P. Kontoyiannis · The Lancet
|
Nov 2003 |
682 |
| 36 |
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
Kai E. Kisand et al. · The Journal of Experimental Medicine
Open access |
Feb 2010 |
675 |
| 37 |
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
MICHAEL J. BYRNE, Anna K. Nowak · Annals of Oncology
Open access |
Feb 2004 |
650 |
| 38 |
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
Aart Jan van der Lely et al. · The Lancet
|
Nov 2001 |
648 |
| 39 |
Myasthenia gravis: recommendations for clinical research standards
Alfred Jaretzki, Richard J. Barohn, Raina M. Ernstoff et al. · The Annals of Thoracic Surgery
Open access |
Jul 2000 |
648 |
| 40 |
Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors
Douglas M. Fambrough, Daniel B. Drachman, Saty Satya‐Murti · Science
|
19 Oct 1973 |
642 |
| 41 |
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
E. P. Krenning, Wout A. P. Breeman, Peter P. M. Kooij et al. · The Lancet
|
Feb 1989 |
628 |
| 42 |
The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes
Alexander Marx, John Chan, Jean‐Michel Coindre et al. · Journal of Thoracic Oncology
Open access |
21 Aug 2015 |
622 |
| 43 |
Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
Jan P. van Meerbeeck, Rabab Mohamed Gaafar, Christian Manegold et al. · Journal of Clinical Oncology
Open access |
28 Sep 2005 |
621 |
| 44 |
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis
Amelia Evoli · Brain
|
23 Jun 2003 |
620 |
| 45 |
Epidemiology of Thymoma and Associated Malignancies
Eric A. Engels · Journal of Thoracic Oncology
Open access |
21 Sep 2010 |
618 |
| 46 |
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients
Raja Michael Flores, Harvey Ira Pass, Venkatraman Seshan et al. · Journal of Thoracic and Cardiovascular Surgery
Open access |
Mar 2008 |
618 |
| 47 |
A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma
Valerie W. Rusch · CHEST Journal
|
Oct 1995 |
611 |
| 48 |
Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes
Vanda A. Lennon, Thomas J. Kryzer, Guy E. Griesmann et al. · New England Journal of Medicine
Open access |
Jun 1995 |
610 |
| 49 |
Thymic hyperplasia and neoplasia: A review of current concepts
Gerald D. Levine, Juan Rosaí · Human Pathology
|
Sep 1978 |
602 |
| 50 |
The World Health Organization histologic classification system reflects the oncologic behavior of thymoma
Meinoshin Okumura, Mitsunori Ohta, Hisashi Tateyama et al. · Cancer
|
31 Jan 2002 |
597 |